The Bath County School District does not discriminate on the basis of race, color, religion, sex, genetic information, national or ethnic origin, political affiliation, age or disabling condition in its programs and activities and provides equal access to the Boy Scouts and other designated youth groups.
The once-yearly infusion of zoledronic acid (Reclast) reduced the risk of vetebral, hip, and other fractures in postmenopausal women with osteoporosis, Dennis M. Black, Ph.D., of the University of California here, and colleagues, reported in the May 3 issue of the New England Journal of Medicine.
Reclast Bone drug (zoledronic acid: once-yearly intravenous infusion) Gets FDA Kidney Failure Warning. MedPage Today/webMD. Published: September 01, 2011. The FDA warns that the osteoporosis drug Reclast (zoledronic acid) raises the risk of kidney failure.. Medications other than Reclast may be more suitable for you if you have kidney problems. The FDA warning says that kidney failure is a rare but serious complication for at-risk patients taking Reclast.